Event Details

ASCO Annual Meeting: Vaccinex, Inc. - Interim results from CLASSICAL-Lung, a Phase Ib/II study of VX15/2503 (pepinemab) in combination with avelumab in advanced NSCLC

04/01/19 at 1:00 PM EDT
Event Details
Title
ASCO Annual Meeting: Vaccinex, Inc. - Interim results from CLASSICAL-Lung, a Phase Ib/II study of VX15/2503 (pepinemab) in combination with avelumab in advanced NSCLC
Date / Time
04/01/19 at 1:00 PM EDT